Cardiac Imaging

The cardiac imaging channel includes the modalities of computed tomography (CT), cardiac ultrasound (echocardiography), magnetic resonance imaging (MRI), nuclear imaging (PET and SPECT), and angiography. 

Videos | Coronavirus (COVID-19)

Keith Ellis, M.D., is the director of cardiovascular services and the director of the Chest Pain Center at Houston ...

Home November 10, 2020
Home
An example of radiation dose tracking software from Imalogix showing data on cath lab angiography cases at RSNA 2019. Photo by Dave Fornell
Feature | Radiation Dose Management | Dave Fornell, Editor

More than a decade ago, there was an alarming, rapid rise in ionizing radiation exposure in the U.S. population that was ...

Home November 04, 2020
Home
This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe.
Feature | Magnetic Resonance Imaging (MRI)

October 29, 2020 — Contrast agents used to improve views of the heart on magnetic resonance imaging (MRI) carry a very ...

Home October 29, 2020
Home
News | Ultrasound Imaging

October 28, 2020 — Northwestern Memorial Hospital is the first hospital in the United States to purchase Caption Health ...

Home October 28, 2020
Home
Chest X-ray, posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.
Feature | Magnetic Resonance Imaging (MRI)

October 27, 2020 – Magnetic resonance imaging (MRI) examinations can be safely performed in patients with non-MR ...

Home October 27, 2020
Home
News | FFR Technologies | Dave Fornell, Editor

October 22, 2020 – In the FORECAST randomized clinical trial, the use of fractional flow reserve (FFR) derived from ...

Home October 22, 2020
Home
News | Cardiovascular Ultrasound

October 13, 2020 — GE Healthcare announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid cardiovascular ...

Home October 15, 2020
Home
The Philips Lumify point-of-care ultrasound (POCUS) system uses an app and a transducer to convert a smartphone into a portable ultrasound system. Philips and GE Healthcare both offer small hand-held systems and are now facing increased competition from new POCUS vendors like Butterfly Network.
Feature | Point-of-Care Ultrasound (POCUS) | Alan Stoddart, Signify Research

For all the changes in medicine there are some things that seem resolutely stable. Chief among these is the idea that ...

Home October 08, 2020
Home
News | Point-of-Care Ultrasound (POCUS)

October 8, 2020 – Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) ...

Home October 08, 2020
Home
News | Nuclear Imaging

September 30, 2020 — Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine ...

Home October 07, 2020
Home
Webinar | Cardiovascular Information Systems (CVIS)

The dynamics of our world are changing rapidly. Cardiologists are being challenged to complete documentation in an ...

Home October 05, 2020
Home
News | Hybrid OR

October 2, 2020 — The new cardiac hybrid operating room (OR) at London Health Sciences Centre (LHSC) in London, Ontario ...

Home October 02, 2020
Home
News | Virtual and Augmented Reality

October 1, 2020 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the SentiAR CommandEP system ...

Home October 01, 2020
Home
The two top DAIC stories in September included the use of point-of-care ultrasound (POCUS) to perform echocardiograms of COVID-19 patients rather than wheeling in larger systems that are more difficult to sanitize. The second top story was on a new trial for Abbott's bioresorbable stent for below-the-knee (BTK) peripheral artery disease lesions. This is a resumption of bioresorbable stent clinical research since the Absorb stent was taken off the market in 2017.
Feature | Dave Fornell, Editor

October 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home October 01, 2020
Home
Subscribe Now